Zurich North America in April 2021 announced the appointment of David Fike as the new head of its Life, Accident & Health business unit. Fike accumulates over 30 years of experience in insurance and pensions, with a special focus on Asia. He has been with Zurich for close to 7 years, lastly as the CEO of General Insurance and Takaful in Malaysia. He previously had worked for CIGNA in Turkey;

Zürich, Switzerland-based broker ASN, Advisory Services Network, in April 2021 appointed Kieran Brown as their General Manager in the UK. Brown’s appointment occurs as ASN enters the post-Brexit UK international insurance market. Brown, who was General Manager of Now Health International Europe (NHI) from 2018 to 2021, comes to ASN with over 25 years of experience in international insurance, having worked for Bupa, AXA PPP Healthcare, Cigna and NHI.

t is well known that companies with operations in multiple countries are in the best position when their employee benefits (EB) plans are controlled centrally. The largest companies have implemented a central function within their HQ that is responsible for EB management. However, in medium-size companies with international operations (i.e., 1’000 – 5’000 employees), this level of control and management is still often non-existent. The key to gaining control

Cells are the basic building blocks of all living things. So, in order to treat or cure almost any disease or condition – including cancer – you first need to have a fundamental understanding of cell biology.. While researchers have a pretty good understanding of what each component of a cell does, there are still things we don’t know about them – including the role that some RNAs molecules play in a cell. Finding the answer to this may be key in developing further cancer treatments, which is what our research has sought to uncover.